Trade ABSI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Absci Corporation (ABSI) is trading at US$8.65, down 2.92% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$1.64B. Over the past 52 weeks, ABSI has traded between US$2.24 and US$12.06. On Syfe you can trade ABSI with $0 commission and add it to your watchlist.
| Previous close | US$8.91 |
|---|---|
| Market cap | US$1.64B |
| 52-week range | US$2.24 – US$12.06 |
| Volume | 1.99M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Absci Corporation
Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Year: 2021
Absci's ABS-201 Phase 1 Data De-Risks Hair Loss Program Ahead of Efficacy Readout, Truist Says
Jun 24, 7:02 PM · MT Newswires
Top Midday Gainers
Jun 24, 5:31 PM · MT Newswires
Absci Corporation (ABSI) stock is trading at US$8.65, -2.92% from the previous close of US$8.91.
The market cap for Absci Corporation (ABSI) stock is approximately US$1.64B.
The 52-week high for Absci Corporation (ABSI) stock is US$12.06.
The 52-week low for Absci Corporation (ABSI) stock is US$2.24.
Absci Corporation (ABSI) does not currently pay a dividend.
Stay on top of ABSI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
